Twist Bioscience Monkeypox Virus Synthetic DNA Controls
Jul 14, 2022
Twist Bioscience has launched two human monkeypox virus synthetic DNA controls.
Positive controls can be used in development and validation of next-generation sequencing and PCR assays. The Twist controls include both known clades of the virus: the Congo Basin (Central African) clade and the West African clade. Made up of 1.8 Kb of overlapping fragments that tile the genome, the controls cover 80 percent of the full viral genome and are sequence verified using NGS and droplet digital PCR.